/countries/thailand/news/webinar_world-hypertension-day-cropped-1.png?sfvrsn=49d9aa0a_3)
Organized by
Department of Health Promotion and Disease Prevention and Control, WHO South-East Asia Regional Office
Why clinically validated BP devices matter most
- Accurate measurement of blood pressure influences the effective diagnosis, treatment, and long-term management of hypertension.
- Most devices in the market and clinical settings are not validated.
- Clinically validated automated BP measurement devices plays significant importance for achieving SEAHEARTS milestone to place 100 million people with hypertension on protocol-based management, with at least 60 million achieving controlled blood pressure by 2030.
Target audiences:
- National programme managers (primary health care, NCDs, UHC, Health systems, Health technology)
- Hospital and facility managers
- Medical device regulatory authorities
- Public procurement authorities and agencies
- Healthcare providers and clinicians
- Nongovernmental organization
- Academic institutes
- Any interested personnel
Webinar objectives
- to build awareness and understanding on importance of improving access and promote use of clinically validated blood pressure measuring devices.
- to discuss and drive actions for national policies and procurement practices, and accelerating the adoption of validated BP devices into national health systems.
Webinar registration link:
https://who.zoom.us/webinar/register/WN_NPHQg9qfQq-yIUZ2UYJCyQ
Upon completing your registration, you will receive a confirmation email containing detailed instructions for joining the webinar.